AUTHORS

Real Money authors - Stephen Guilfoyle

Stephen Guilfoyle

Stephen "Sarge" Guilfoyle is the founder and President of Sarge986 LLC, a family run trading operation. An NYSE floor trader for over 30 years, Guilfoyle has served as the Chief Market Economist for Stuart Frankel & Co., the U.S. Economist for Meridian Equity Partners, and as a Vice President in Block Trading and Investment Banking with Credit Suisse over the years. Guilfoyle earned his nickname serving as an actual sergeant in reserve components of the US Marine Corps, and US Army while simultaneously working on Wall Street.
Email Stephen Guilfoyle

Recent Articles By The Author

The Band Plays On, Risky Business, Keep Your Eyes Open, Down Memory Lane

Plus, a look at what's going on inside the trader's brain as he looks at Walt Disney, Airbnb and SoFi Technologies.

Here's How I'm Playing Palantir Now

Try this options strategy on PLTR's solid earnings.

Economic Growth? Trading Volume, OPEC+ Production, Vaccine Booster

These guys are aware that the U.S. was energy independent less than a year and a half ago, right?

Coinbase Offers a Put Options Play After Its Post-Earnings Jump

The stock of the cryptocurrency exchange could be vulnerable due to an unclear outlook and possible industry regulation ahead.

Fiscal Landscape, Spending Packages, CPI, Trading the Semis, Cleveland Cliffs

Also, the NFIB Small Business Optimism Index printed at 99.7 for July, still on the strong side, but well below June's print, and well below expectations.

Taking Profits and Building a Plan for 3D Systems

Try an options strategy while waiting for the gap to fill in this name.

Market Chop Top, Witches' Brew for the Economy, Federal Reserve, Trading AMC

We hear so much about how there will be an everything rally once the Delta variant peaks. We have not already had 'an everything' rally?

The Messenger RNA Vaccine Stocks Are the Best Investment Against COVID

The Pfizer and Moderna vaccines are the most easily adjustable and quickest to manufacture as versatility will remain key.

Bond Yields, Infrastructure Bill, Job Creation, Earnings, Vaccine Booster Shots

One thing we know is that the current wave of the pandemic just seems to be getting worse.

For Now, Moderna Is an Options Play For Me

The shares are only trading at 17 times forward earnings, and might not be fully valued just yet.

Email sent

Thank you, your email to has been sent successfully.

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight